Organization Overview
Alternative names
basiliximab (Simulect) (2 trials)
bortezomib (velcade) (2 trials)
budesonide (rhinocort) (1 trial)
casein phosphopeptide amorphous calcium phosphate (1 trial)
ceftriaxone (rocephin) (1 trial)
dexmedetomidine (precedex) (2 trials)
etoposide (vepesid) (5 trials)
immune globulin (human) (Gamastan) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
131i-lipiodol (Lipiodol) (1 trial)
acetylsalicylic acid (aspirin) (2 trials)
allogeneic stem cells (1 trial)
amlodipine (norvasc) (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
azacitidine (vidaza) (5 trials)
bevacizumab (avastin) (5 trials)
bone marrow derived mesenchymal stem cells (1 trial)
capecitabine (xeloda) (12 trials)
cd123/cll1 car-t cells (1 trial)
cladribine (leustatin) (3 trials)
clopidogrel (plavix) (1 trial)
cyclophosphamide (cytoxan) (10 trials)
cytarabine (cytosar-u) (8 trials)
docetaxel (taxotere) (7 trials)
doxorubicin (Doxil) (4 trials)
endostatin (endostar) (4 trials)
epirubicin (ellence) (1 trial)
erlotinib (tarceva) (4 trials)
Filgrastim (neupogen) (3 trials)
fludarabine (fludara) (7 trials)
fluorouracil (efudex) (18 trials)
hydromorphone (diladid) (3 trials)
idarubicin (idamycin) (1 trial)
indocyanine green (ic-green) (6 trials)
irinotecan (Camptosar) (10 trials)
itraconazole (sporanox) (1 trial)
lenalidomide (revlimid) (3 trials)
levoleucovorin (fusilev) (11 trials)
nitric oxide (inomax) (1 trial)
pemetrexed (alimta) (2 trials)
posaconazole (noxafil) (1 trial)
ranibizumab (lucentis) (1 trial)
rasagiline (azilect) (1 trial)
rituximab (rituxan) (4 trials)
sargramostim (leukine) (3 trials)
tamoxifen (nolvadex) (1 trial)
toremifene (fareston) (1 trial)
vincristine (oncovin) (5 trials)
afatinib (gilotrif) (2 trials)
aldesleukin (Proleukin) (3 trials)
carboplatin (paraplatin) (5 trials)
caspofungin (cancidas) (1 trial)
duvelisib (copiktra) (1 trial)
enoxaparin (lovenox) (1 trial)
evolocumab (repatha) (1 trial)
fingolimod (gilenya) (2 trials)
fulvestrant (faslodex) (2 trials)
furmonertinib (Ives) (1 trial)
lapatinib (tykerb) (15 trials)
lenvatinib (lenvima) (1 trial)
masct:multiple antigens specific cellular therapy (1 trial)
mitoxantrone (novantrone) (1 trial)
obinutuzumab (gazyva) (1 trial)
pertuzumab (perjeta) (1 trial)
pirfenidone (esbriet) (1 trial)
recombinant human adenovirus type 5 (3 trials)
sevoflurane (ultane) (1 trial)
tipiracil (lonsurf) (2 trials)
toripalimab (LOQTORZ) (3 trials)
trastuzumab (herceptin) (2 trials)
umbilical cord mesenchymal stem cells (4 trials)
amniotic epithelial cells (3 trials)
autologous humanized anti-cd19 and anti-cd20 dual specific car-t cells (1 trial)
bromocriptine (parlodel) (2 trials)
cabergoline (dostinex) (3 trials)
hemopoietic stem cell (1 trial)
human fecal microbiota (Reybota) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma of Lung (Phase 2)
Agranulocytosis (Phase 2)
Arthritis (Phase 1)
Arthritis, Rheumatoid (Phase 1)
Atherosclerosis (Phase 3)
Atrophy (Phase 2)
Basal Ganglia Hemorrhage (Phase 2)
beta-Thalassemia (Phase 4)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Bronchial Fistula (Phase 1)
Bronchopulmonary Dysplasia (Phase 3)
Cancer Pain (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Adenosquamous (Phase 2)
Carcinoma, Hepatocellular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Cerebral Infarction (Phase 4)
Cerebral Palsy (Phase 1)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Coronavirus Infections (Phase 2)
Cryptorchidism (Phase 2)
Delirium (Phase 4)
Dental Caries (Phase 1)
Dyspepsia (Phase 2)
Emergence Delirium (Phase 4)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Essential Hypertension (Phase 3)
Fibrosis (Phase 2)
Fistula (Phase 1)
Ganglion Cysts (Phase 2)
Gonorrhea (Phase 4)
Graft vs Host Disease (Phase 4)
Hematoma (Phase 2)
Hernia, Inguinal (Phase 2)
Hyperhomocysteinemia (Phase 3)
Hypertension (Phase 3)
Inflammation (Phase 2)
Intracranial Arteriosclerosis (Phase 3)
Iron Metabolism Disorders (Phase 1)
Ischemia (Phase 4)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 4)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, T-Cell (Phase 1)
Liver Cirrhosis (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 4)
Lupus Nephritis (Phase 4)
Lymphatic Metastasis (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoproliferative Disorders (Phase 1)
Malnutrition (Phase 3)
Melanoma (Phase 2)
Multiple Myeloma (Phase 4)
Multiple System Atrophy (Phase 2)
Muscle Spasticity (Phase 2)
Mycoses (Phase 2)
Nasopharyngeal Carcinoma (Phase 3)
Nausea (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms, Plasma Cell (Phase 4)
Neoplasms, Second Primary (Phase 2)
Nephritis (Phase 4)
Neurodegenerative Diseases (Phase 1)
Pain, Intractable (Phase 4)
Pancreatic Neoplasms (Phase 2)
Paraplegia (Phase 2)
Psoriasis (Phase 2)
Recurrence (Phase 3)
Respiratory Aspiration (Phase 4)
Shy-Drager Syndrome (Phase 2)
Spastic Paraplegia, Hereditary (Phase 2)
Spinal Cord Diseases (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Strabismus (Phase 4)
Stroke (Phase 4)
Synovial Cyst (Phase 2)
Thalassemia (Phase 4)
Thrombosis (Phase 3)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Tooth Erosion (Phase 4)
Tuberculosis (Phase 3)
Vomiting (Phase 4)